The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials Ya LuoKai LuXiaoli Zhou Systematic Review 25 September 2018 Pages: 1089 - 1108
Cardiovascular Toxicities with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Meta-Analysis of 77 Randomized Controlled Trials Jing LiJian Gu Systematic Review 16 October 2018 Pages: 1109 - 1123
Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization Hsiang-Yin ChenPei-Yin ChiuJason C. Hsu Original Research Article 15 September 2018 Pages: 1125 - 1133
Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout Tatsuo HosoyaTomohiko IshikawaTetsuo Ohashi Original Research Article Open access 15 September 2018 Pages: 1135 - 1143
Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects Chaoying HuXiao HuLan Zhang Original Research Article 19 September 2018 Pages: 1145 - 1154
Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence Sara NazhaSimon TanguayAlice Dragomir Original Research Article 28 September 2018 Pages: 1155 - 1165
Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review Jie FuYuchen LiuBin Wu Original Research Article 19 September 2018 Pages: 1167 - 1178
Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015 Yeon-Hee BaekSang Jun ParkJu-Young Shin Original Research Article 01 October 2018 Pages: 1179 - 1188
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings Hiroki KoshimichiToru IshibashiToshihiro Wajima Original Research Article Open access 04 October 2018 Pages: 1189 - 1196
Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database Philippe Picaut Letter to the Editor Open access 03 November 2018 Pages: 1197 - 1198
Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database” Rashid KazerooniEdward P. Armstrong Letter to the Editor 03 November 2018 Pages: 1199 - 1200